This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

Michael R. Mcmullen net worth and biography

Michael Mcmullen Biography and Net Worth

CEO of Agilent Technologies

Mike McMullen was appointed Agilent CEO in March 2015, replacing William (Bill) Sullivan.

McMullen has more than 30 years of industry experience and senior management experience at Agilent. He was president of the company's Chemical Analysis Group from 2009 until November 2014.

As head of CAG, McMullen transformed the business, consistently delivering market-leading growth and profits. He championed strategic acquisitions and architected Agilent's China strategy. He built the Agilent CrossLab Group, which includes services, software and consumables; ACG was made one of Agilent's three major businesses in September 2014. McMullen also has significant international experience, having lived in Japan, where he led Agilent's Japan field sales and support operations, later adding responsibility for China field operations. He is recognized for his inspirational leadership style.

McMullen joined Agilent's predecessor, Hewlett-Packard Co., in 1984 as a financial analyst. He holds a bachelor's degree in economics and business administration from the University of Delaware and an MBA from the Wharton School of Business. McMullen also serves on the Board of Directors for Coherent, Inc.

What is Michael R. Mcmullen's net worth?: The estimated net worth of Michael R. Mcmullen is at least $34.91 million as of March 8th, 2024. Mr. Mcmullen owns 253,909 shares of Agilent Technologies stock worth more than $34,909,948 as of April 25th. This net worth evaluation does not reflect any other assets that Mr. Mcmullen may own. Learn More about Michael R. Mcmullen's net worth.
How do I contact Michael R. Mcmullen?: The corporate mailing address for Mr. Mcmullen and other Agilent Technologies executives is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. Agilent Technologies can also be reached via phone at (800) 227-9770 and via email at [email protected]. Learn More on Michael R. Mcmullen's contact information.
Has Michael R. Mcmullen been buying or selling shares of Agilent Technologies?: Michael R. Mcmullen has not been actively trading shares of Agilent Technologies in the last ninety days. Most recently, Michael R. Mcmullen sold 52,297 shares of the business's stock in a transaction on Friday, March 8th. The shares were sold at an average price of $150.00, for a transaction totalling $7,844,550.00. Following the completion of the sale, the chief executive officer now directly owns 253,909 shares of the company's stock, valued at $38,086,350. Learn More on Michael R. Mcmullen's trading history.
Who are Agilent Technologies' active insiders?: Agilent Technologies' insider roster includes Henrik Ancher-Jensen (SVP), Philip Binns (SVP), Heidi Fields (Director), Rodney Gonsalves (VP), Dominique Grau (SVP), Boon Koh (Director), Padraig Mcdonnell (VP), Michael Mcmullen (CEO), Samraat Raha (VP), Michael Tang (SVP), and Jacob Thaysen (VP). Learn More on Agilent Technologies' active insiders.
Are insiders buying or selling shares of Agilent Technologies?: In the last twelve months, Agilent Technologies insiders bought shares 1 times. They purchased a total of 3 shares worth more than $333.27. In the last twelve months, insiders at the medical research company sold shares 11 times. They sold a total of 161,983 shares worth more than $22,489,381.86. The most recent insider tranaction occured on March, 25th when SVP Philip Binns sold 2,827 shares worth more than $417,095.58. Learn More about insider trades at Agilent Technologies.
Information on this page was last updated on 3/25/2024.

Michael R. Mcmullen Insider Trading History at Agilent Technologies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/8/2024	Sell	52,297	$150.00	$7,844,550.00	253,909
12/13/2023	Sell	2,751	$130.00	$357,630.00	306,206
12/7/2023	Sell	62,467	$130.00	$8,120,710.00	306,206
7/27/2023	Sell	944	$130.00	$122,720.00	260,869
11/22/2022	Sell	128,726	$155.73	$20,046,499.98	260,691
11/16/2022	Sell	6,775	$148.19	$1,003,987.25	270,896
11/2/2022	Sell	6,775	$140.61	$952,632.75	191,358
10/26/2022	Sell	6,775	$134.43	$910,763.25	191,358
10/19/2022	Sell	6,775	$130.11	$881,495.25	191,358
12/20/2021	Sell	123,459	$148.82	$18,373,168.38
4/22/2021	Sell	9,053	$135.00	$1,222,155.00	261,105
4/13/2021	Sell	8,966	$132.50	$1,187,995.00	270,158
4/8/2021	Sell	15,095	$130.26	$1,966,274.70	279,124
2/1/2021	Sell	21,212	$120.26	$2,550,955.12	356,963
12/1/2020	Sell	85,842	$115.63	$9,925,910.46	415,347
7/30/2020	Sell	72,716	$95.76	$6,963,284.16	575,215
5/8/2020	Sell	18,018	$80.00	$1,441,440.00
4/29/2020	Sell	13,603	$78.72	$1,070,828.16	529,245
4/27/2020	Sell	8,814	$76.20	$671,626.80	542,848
12/10/2019	Sell	24,636	$82.90	$2,042,324.40	332,121
11/25/2019	Sell	24,636	$80.00	$1,970,880.00	332,121
9/12/2019	Sell	24,635	$77.50	$1,909,212.50
3/1/2019	Sell	8,745	$80.00	$699,600.00	438,939
2/15/2019	Sell	8,746	$77.67	$679,301.82	447,684
1/30/2019	Sell	17,491	$75.00	$1,311,825.00	456,430
12/3/2018	Sell	15,923	$73.20	$1,165,563.60	492,546
1/29/2018	Sell	21,850	$75.00	$1,638,750.00	324,687
1/18/2018	Sell	21,850	$72.50	$1,584,125.00	324,687
1/5/2018	Sell	43,703	$70.00	$3,059,210.00	302,837
11/20/2017	Sell	22,481	$70.00	$1,573,670.00	327,882
11/17/2017	Sell	22,481	$68.77	$1,546,018.37	336,637
9/14/2017	Sell	16,492	$65.33	$1,077,422.36	211,872
5/23/2017	Sell	50,000	$59.86	$2,993,000.00
5/1/2017	Sell	32,511	$55.48	$1,803,710.28	260,346
5/19/2016	Sell	124,411	$44.46	$5,531,313.06	171,473
4/14/2015	Sell	43,130	$42.72	$1,842,513.60
6/23/2014	Sell	35,377	$58.56	$2,071,677.12
6/19/2013	Sell	43,253	$44.66	$1,931,678.98

Michael R. Mcmullen Buying and Selling Activity at Agilent Technologies

Agilent Technologies Company Overview

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Today's Range

Now: $135.37

$135.18

$137.21

50 Day Range

MA: $141.50

$131.49

$149.36

2 Week Range

Now: $135.37

$96.80

$151.58

Volume

52,718 shs

Average Volume

1,561,143 shs

Market Capitalization

$39.67 billion

P/E Ratio

32.23

Dividend Yield

0.68%

Beta

1.11